Glutathione

Glutathione

SCHEMBL1105665

NC(CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O)C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 1.00
GSTK1 Q9Y2Q3 1/20 1.00
GLO1 Q04760 2/20 0.65
NOD1 Q9Y239 7/20 0.46
FOLH1 Q04609 2/20 0.43
GRM8 O00222 1/20 0.43
GRM6 O15303 1/20 0.43
GRIN2D O15399 1/20 0.43
GRIN3B O60391 1/20 0.43
GSR P00390 1/20 0.43
CYP1A2 P05177 1/20 0.43
GRIK1 P39086 1/20 0.43
GRM5 P41594 1/20 0.43
GRIA1 P42261 1/20 0.43
GRIA2 P42262 1/20 0.43
GRIA3 P42263 1/20 0.43
SLC1A3 P43003 1/20 0.43
SLC1A2 P43004 1/20 0.43
SLC1A1 P43005 1/20 0.43
GRIA4 P48058 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glutathione SCHEMBL28505216 1.00 PTGS1 (1.00) PTGS1GSTK1GLO1NOD1FOLH1
Glutathione SCHEMBL14364095 1.00 PTGS1 (1.00) PTGS1GSTK1GLO1NOD1FOLH1
Glutathione SCHEMBL272141 1.00 PTGS1 (1.00) PTGS1GSTK1GLO1NOD1FOLH1
Glutathione SCHEMBL5167025 1.00 PTGS1 (1.00) PTGS1GSTK1GLO1NOD1FOLH1
Glutathione SCHEMBL5167030 1.00 PTGS1 (1.00) PTGS1GSTK1GLO1NOD1FOLH1
Glutathione SCHEMBL13105609 1.00 PTGS1 (1.00) PTGS1GSTK1GLO1NOD1FOLH1
Glutathione SCHEMBL7469803 1.00 PTGS1 (1.00) PTGS1GSTK1GLO1NOD1FOLH1
Glutathione SCHEMBL9167 1.00 PTGS1 (1.00) PTGS1GSTK1GLO1NOD1FOLH1
Glutathione SCHEMBL15701576 1.00 PTGS1 (1.00) PTGS1GSTK1GLO1NOD1FOLH1
Glutathione SCHEMBL30733475 1.00 PTGS1 (1.00) PTGS1GSTK1GLO1NOD1FOLH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230382946-A1 POLYPEPTIDE OR PROTEIN DIRECTIONAL MODIFICATION METHOD BASED ON SULFHYDRYL-ALKENYL AZIDE COUPLING Changzhou University (CN) 2023-11-30 US disclosed
US-11534475-B2 Carbohydrate-based peritoneal dialysis fluid comprising glutamine residue ZYTOPROTEC GMBH (AT) 2022-12-27 US disclosed
CN-114317647-A Method for producing glutathione by using genetic engineering escherichia coli 无锡福祈制药有限公司 2022-04-12 CN disclosed
CN-108473484-B Compounds useful as TRPM8 modulators 弗门尼舍公司 2021-06-29 CN disclosed
CN-109709182-B Based on g-C3N4-MnO2Method for ultrasensitive detection of glutathione by photo-electrochemical method of nano composite material 济南大学 2021-03-26 CN disclosed
US-20200281235-A1 METHOD FOR MANUFACTURING SEASONING MITSUBISHI CORPORATION LIFE SCIENCES LIMITED (JP) 2020-09-10 US disclosed
CN-105712964-B Preparation method and application of thiol fluorescent probe based on coumaroyl hydrazide 新乡医学院 2020-07-07 CN disclosed
US-10688122-B2 Thiol and disulfide-containing agents for increasing meibomian gland lipid secretion Azura Ophthalmics Ltd. (IL) 2020-06-23 US disclosed
US-20200113965-A1 CARBOHYDRATE-BASED PERITONEAL DIALYSIS FLUID COMPRISING GLUTAMINE RESIDUE ZYTOPROTEC GMBH (AT) 2020-04-16 US disclosed
CN-109709182-A A kind of g-C3N4-MnO2The photic electrochemical process super sensitivity detection glutathione of nanocomposite 济南大学 2019-05-03 CN disclosed
EP-2129370-A1 CARBOHYDRATE-BASED PERITONEAL DIALYSIS FLUID COMPRISING GLUTAMINE RESIDUE Zytoprotec Gmbh (AT) 2009-12-09 EP disclosed
US-20080255226-A1 STABILIZED ANTHOCYANIN COMPOSITIONS OMNICA GMBH (DE) 2008-10-16 US disclosed
WO-2008106702-A1 CARBOHYDRATE-BASED PERITONEAL DIALYSIS FLUID COMPRISING GLUTAMINE RESIDUE ZYTOPROTEC GMBH (AT) 2008-09-12 WO disclosed
WO-2008066816-A2 DERIVATIZATION OR LIGATON OF PEPTIDES THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2008-06-05 WO disclosed
US-20070148712-A1 Breast cancer and prostate cancer assessment IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2007-06-28 US disclosed
WO-2006133408-A9 BREAST CANCER AND PROSTATE CANCER ASSESSMENT UNIV IOWA STATE RES FOUND INC (US) 2007-04-12 WO disclosed
WO-2006133408-A2 BREAST CANCER AND PROSTATE CANCER ASSESSMENT IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2006-12-14 WO disclosed
EP-0300168-B1 PROCESS FOR THE GLUTATHIONE SYNTHESIS IN YEAST HÜLS AKTIENGESELLSCHAFT (DE) 1993-01-13 EP disclosed
EP-0300168-A2 Process for the glutathione synthesis in yeast HÜLS AKTIENGESELLSCHAFT (DE) 1989-01-25 EP disclosed
EP-0300168-A2 Process for the glutathione synthesis in yeast HÜLS AKTIENGESELLSCHAFT (DE) 1989-01-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10688122-B2 Thiol and disulfide-containing agents for increasing meibomian gland lipid secretion TXN, MGST3, MGST1 PTGS1 227/4885GSTK1 31/4885GLO1 201/4885
US-20080255226-A1 STABILIZED ANTHOCYANIN COMPOSITIONS NQO1, CRY2, GANC PTGS1 2891/4885GSTK1 2995/4885GLO1 474/4885
US-20230382946-A1 POLYPEPTIDE OR PROTEIN DIRECTIONAL MODIFICATION METHOD BASED ON SULFHYDRYL-ALKENYL AZIDE COUPLING PTMS, CBS, CHAMP1 PTGS1 2134/4885GSTK1 496/4885GLO1 519/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.